文献速递脑血管病外科神经重症

兰尼碱受体1基因多态性与动脉瘤性蛛网膜下腔出血及其临床后遗症无关

Ryanodine Receptor 1 Polymorphism Is Not Associated with Aneurysmal Subarachnoid Hemorrhage or its Clinical Sequelae.
PubMed 文献 · World Neurosurg · 2017-01-10

本研究利用CARAS研究入组患者的血样,采用Taqman基因分型法检测RYR1单核苷酸多态性rs35364374,分析其与动脉瘤性蛛网膜下腔出血(aSAH)及临床后遗症的关系。纳入149例aSAH患者和50例对照,多因素回归分析未发现该多态性与aSAH相关,也未发现其与临床血管痉挛、迟发性脑缺血、出院时功能结局或末次随访功能结局相关。结论与既往报道相反。

要点

  • RYR1 SNP rs35364374与动脉瘤性蛛网膜下腔出血无关。
  • 该多态性与临床血管痉挛、迟发性脑缺血及功能结局均无关。
  • 结论与既往报道的RYR多态性与脑血管痉挛相关相反。

核心结论

  • 与既往报道相反,RYR1 SNP rs35364374与动脉瘤性蛛网膜下腔出血及其临床后遗症无关。

研究设计与样本

  • 利用CARAS(脑动脉瘤肾素血管紧张素系统)研究入组患者的血样进行遗传学评估,采用5'核酸外切酶(Taqman)基因分型法检测RYR1 SNP rs35364374。
  • 样本包括149例动脉瘤性蛛网膜下腔出血患者和50例对照。

主要发现

  • 多因素回归分析未显示RYR1 SNP rs35364374与动脉瘤性蛛网膜下腔出血相关。
  • RYR1 SNP rs35364374与临床血管痉挛、迟发性脑缺血、出院时功能结局及末次随访功能结局均无关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The pathophysiologic mechanisms underlying cerebral vasospasm after aneurysmal subarachnoid hemorrhage (aSAH) remain poorly understand. Ryanodine receptors (RYR) are intracellular calcium channels involved in the regulation of vascular smooth muscle cells and cerebrovascular tone and diameter. Previous work reported an association between an RYR polymorphism and cerebral vasospasm. Here, we sought to assess the impact of that RYR polymorphism on aSAH and its clinical sequelae. METHODS: Blood samples from all patients enrolled in the CARAS (Cerebral Aneurysm Renin Angiotensin System) study were used for genetic evaluation. The RYR1 single nucleotide polymorphism (SNP) rs35364374 was detected using 5'exonuclease (Taqman) genotyping assays. Associations between the RYR1 polymorphism and aSAH and its clinical sequelae were analyzed. RESULTS: Samples from 149 patients with aSAH and 50 controls were available for analysis. Multivariable regression analysis did not show an association of RYR1 SNP rs35364374 with aSAH. Moreover, there was no association of RYR1 SNP rs35364374 with clinical vasospasm, delayed cerebral ischemia, functional outcome at discharge, or functional outcome at last follow-up. CONCLUSIONS: Contrary to a previous report, the RYR1 SNP rs35364374 was not associated with aSAH or its clinical sequelae.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Hendrix P, Foreman PM, Harrigan MR, et al. Ryanodine Receptor 1 Polymorphism Is Not Associated with Aneurysmal Subarachnoid Hemorrhage or its Clinical Sequelae. World Neurosurg. 2017. PMID: 28087430. doi:10.1016/j.wneu.2016.12.132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。